Viewing Study NCT05647512


Ignite Creation Date: 2025-12-26 @ 11:07 AM
Ignite Modification Date: 2026-02-23 @ 8:56 PM
Study NCT ID: NCT05647512
Status: WITHDRAWN
Last Update Posted: 2023-11-18
First Post: 2022-12-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of LM-305 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) and Other Plasma Cell Diseases
Sponsor: LaNova Medicines Limited
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-01-18
Start Date Type: ESTIMATED
Primary Completion Date: 2024-12-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-12-30
Completion Date Type: ESTIMATED
First Submit Date: 2022-12-01
First Submit QC Date: None
Study First Post Date: 2022-12-12
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-11-15
Last Update Post Date: 2023-11-18
Last Update Post Date Type: ACTUAL